Search research articles
Contact Us
Filters
Showing results (11-20 of 118) with videos related to
Page
of 12
Sort By:
British Journal of Haematology
|
September 12, 2018
Extreme hyperferritinaemia, soluble interleukin-2 receptor, and haemophagocytic lymphohistiocytosis
Luke Y C Chen, Anna Hayden, Andre Mattman
The Lancet. Microbe
|
June 8, 2021
Combining immunomodulators and antivirals for COVID-19
Luke Y C Chen, Tien T T Quach
The New England Journal of Medicine
|
April 16, 2025
Hemophagocytic Lymphohistiocytosis
Luke Y C Chen, Mariam Goubran, Caroline Spaner
British Journal of Haematology
|
February 19, 2026
In response to Bergonzi et al.: Azacitidine-ruxolitinib combination therapy may permit dose reduction in VEXAS syndrome
Jeremiah Tan, Natasha Dehghan, Luke Y C Chen
Rheumatology (Oxford, England)
|
March 9, 2024
Comment on: Lymphadenopathy in the rheumatology practice: a pragmatic approach
Emily Leung, Collin Pryma, Luke Y C Chen
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
July 6, 2021
Kevin Afra, Luke Y C Chen, David Sweet
British Journal of Haematology
|
June 9, 2021
Treatment of lymphocyte-variant hypereosinophilic syndrome (L-HES): what to consider after confirming the elusive diagnosis
Alastair K Williams, Carol Dou, Luke Y C Chen
British Journal of Haematology
|
October 27, 2024
Goodbye etoposide? Taking the leap to ruxolitinib in haemophagocytic lymphohistiocytosis
Samuel A Merrill, Caroline Spaner, Luke Y C Chen
JAAD Case Reports
|
August 8, 2019
Lymphocyte-variant hypereosinophilic syndrome presenting as chronic dermatitis and responding to mycophenolic acid
Carol Dou, Luke Y C Chen, Jan P Dutz
Arthritis & Rheumatology (Hoboken, N.J.)
|
June 3, 2025
Expert Perspective: Diagnosis and Treatment of Castleman Disease
Luke Y C Chen, Lu Zhang, David C Fajgenbaum
Page
of 12
Search research articles
Search
Showing results (11-20 of 118) with videos related to
Sort By:
Page
of 12
British Journal of Haematology
|
September 12, 2018
Extreme hyperferritinaemia, soluble interleukin-2 receptor, and haemophagocytic lymphohistiocytosis
Luke Y C Chen, Anna Hayden, Andre Mattman
The Lancet. Microbe
|
June 8, 2021
Combining immunomodulators and antivirals for COVID-19
Luke Y C Chen, Tien T T Quach
The New England Journal of Medicine
|
April 16, 2025
Hemophagocytic Lymphohistiocytosis
Luke Y C Chen, Mariam Goubran, Caroline Spaner
British Journal of Haematology
|
February 19, 2026
In response to Bergonzi et al.: Azacitidine-ruxolitinib combination therapy may permit dose reduction in VEXAS syndrome
Jeremiah Tan, Natasha Dehghan, Luke Y C Chen
Rheumatology (Oxford, England)
|
March 9, 2024
Comment on: Lymphadenopathy in the rheumatology practice: a pragmatic approach
Emily Leung, Collin Pryma, Luke Y C Chen
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
July 6, 2021
Kevin Afra, Luke Y C Chen, David Sweet
British Journal of Haematology
|
June 9, 2021
Treatment of lymphocyte-variant hypereosinophilic syndrome (L-HES): what to consider after confirming the elusive diagnosis
Alastair K Williams, Carol Dou, Luke Y C Chen
British Journal of Haematology
|
October 27, 2024
Goodbye etoposide? Taking the leap to ruxolitinib in haemophagocytic lymphohistiocytosis
Samuel A Merrill, Caroline Spaner, Luke Y C Chen
JAAD Case Reports
|
August 8, 2019
Lymphocyte-variant hypereosinophilic syndrome presenting as chronic dermatitis and responding to mycophenolic acid
Carol Dou, Luke Y C Chen, Jan P Dutz
Arthritis & Rheumatology (Hoboken, N.J.)
|
June 3, 2025
Expert Perspective: Diagnosis and Treatment of Castleman Disease
Luke Y C Chen, Lu Zhang, David C Fajgenbaum
Page
of 12